Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 1 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
4/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$10M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -197%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~18.6% on $1M of debt. Interest last disclosed in FY2020 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
No current price collected.
Where each multiple sits in its own 14-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | — | — | 87.3 | — | 23.4 | 24.2 | 61.0 | 46.0 |
| Gross Profit | — | — | 12.7 | — | 76.6 | 75.8 | 39.0 | 54.0 |
| R&D | — | — | 151.7 | — | 24.5 | 8.9 | 9.9 | 361.7 |
| SG&A | — | — | 2670.9 | — | 468.7 | 333.3 | 391.9 | 2633.4 |
| Operating Income | — | — | -2978.4 | — | -441.2 | -281.1 | -378.2 | -3233.6 |
| Net Income | — | — | -1836.3 | — | -441.3 | -279.3 | -378.1 | -3221.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on AERG: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $462K 100.0% | $2.4M 100.0% | $2.6M 100.0% | $1.3M 100.0% | — | $176K 100.0% | — | — | — | — |
| Cost of Revenue | $213K 46.0% | $1.5M 61.0% | $638K 24.2% | $306K 23.4% | — | $154K 87.3% | — | — | — | — |
| Gross Profit | $249K 54.0% | $947K 39.0% | $2.0M 75.8% | $1.0M 76.6% | — | $22K 12.7% | — | — | — | $0 |
| Research & Development | $1.7M 361.7% | $239K 9.9% | $234K 8.9% | $321K 24.5% | $282K | $267K 151.7% | $335K | $190K | — | — |
| Selling, General & Admin | $12.2M 2633.4% | $9.5M 391.9% | $8.8M 333.3% | $6.1M 468.7% | $4.9M | $4.7M 2670.9% | $4.6M | $2.5M | $752K | $495K |
| Total Operating Expenses | $15.2M 3287.5% | $10.1M 417.2% | $9.4M 356.8% | $6.8M 517.8% | $5.5M | $5.3M 2991.1% | $5.2M | $2.8M | $752K | $495K |
| Operating Income | -$14.9M -3233.6% | -$9.2M -378.2% | -$7.4M -281.1% | -$5.8M -441.2% | -$5.5M | -$5.2M -2978.4% | -$5.2M | -$2.8M | -$752K | -$495K |
| Interest Expense | — | — | — | — | — | $211K 119.9% | $397K | $19K | $3K | — |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | $22 |
| Other Income (Expense), net | $58K 12.5% | $2K 0.1% | $46K 1.7% | -$2K -0.2% | $77K | $2.0M 1142.1% | -$385K | -$245K | -$38K | $3K |
| Pretax Income | -$14.9M -3221.1% | -$9.2M -378.1% | -$7.4M -279.3% | -$5.8M -441.3% | -$5.4M | -$3.2M -1836.3% | -$5.6M | -$3.0M | -$790K | -$493K |
| Income Tax Expense | — | — | — | — | — | — | — | — | — | $0 |
| Net Income | -$14.9M -3221.1% | -$9.2M -378.1% | -$7.4M -279.3% | -$5.8M -441.3% | -$5.4M | -$3.2M -1836.3% | -$5.6M | -$3.0M | -$790K | -$493K |
| Per Share | ||||||||||
| EPS (Basic) | $-0.07 | $-0.04 | $-0.03 | $-0.03 | $-0.03 | $-0.02 | — | — | — | — |
| EPS (Diluted) | $-0.07 | $-0.04 | $-0.03 | $-0.03 | $-0.03 | — | — | — | — | — |
| Weighted Avg Shares (Basic) | 224.0M | 212.9M | 211.1M | 208.1M | 200.9M | — | — | — | — | — |
| Weighted Avg Shares (Diluted) | 224.0M | 212.9M | 211.1M | 208.1M | 200.9M | 193.5M | — | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.